Kailera Therapeutics, Inc.

Pharmaceutical company · Waltham, Massachusetts, United States · Nasdaq: KLRA

Kailera Therapeutics, Inc. is a pharmaceutical company headquartered in Waltham, Massachusetts, United States. Its shares trade on Nasdaq under the ticker KLRA.

Profile compiled from public records. Is this your company? Request a correction or update

Kailera Therapeutics at a glance

Typepharmaceutical company

HeadquartersWaltham, Massachusetts, United States

Stock listingNasdaq: KLRA

SEC industryPharmaceutical Preparations

SEC CIK2096997

Frequently asked questions about Kailera Therapeutics

Where is Kailera Therapeutics headquartered?

Kailera Therapeutics, Inc. is headquartered in Waltham, Massachusetts, United States.

What does Kailera Therapeutics do?

Kailera Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Kailera Therapeutics a public company?

Yes. Kailera Therapeutics, Inc. trades on Nasdaq under the ticker KLRA.

Similar companies

Mustang Bio, Inc.Waltham, Massachusetts, United States
Alkermes IncWaltham, Massachusetts, United States
Spyre Therapeutics, Inc.Waltham, Massachusetts, United States
Cogent Biosciences, Inc.Waltham, Massachusetts, United States
Viridian Therapeutics, Inc.\DEWaltham, Massachusetts, United States
Dyne Therapeutics, Inc.Waltham, Massachusetts, United States
Korsana Biosciences, Inc.Waltham, Massachusetts, United States
Jade Biosciences, Inc.Waltham, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences